PARProceedings of Anticancer Research2208-35452208-3553Bio-Byword Scientific Publishing Pty. Ltd.10.26689/par.v8i6.8907ArticleA Prognostic Nomogram Based on Log Odds of Positive Lymph Nodes for Patients with Gastroenteropancreatic Neuroendocrine Tumorshttps://artdesignp.com/journal/PAR/8/6/10.26689/par.v8i6.8907XuJinsheng,XuYujie2024862024-11-22Objective: To explore the prognostic value of log odds of positive lymph nodes (LODDS) in patients with gastroenteropancreatic neuroendocrine tumors (GEPNET) and to develop nomograms based on LODDS for predicting 1-year, 3-year, and 5-year overall survival (OS) and cancer-specific survival (CSS). Methods: This retrospective cohort study was based on the Surveillance, Epidemiology, and End Results (SEER) Program. Demographic data, clinical data, and survival status were extracted, with endpoints of OS and CSS. Multivariate Cox proportional hazards regression analysis assessed predictors associated with OS and CSS, with hazard ratios (HRs) and 95% confidence intervals (CIs) evaluated. Nomogram performance was assessed by calculating the area under the receiver operating characteristic (ROC) curve (AUC). Results: A total of 1,673 patients were included and divided into a training set (n = 1,172) and a testing set (n = 501). Multivariate Cox proportional hazards regression analyses identified LODDS as an independent prognostic factor for OS (HR = 1.79, 95% CI: 1.44–2.24) and CSS (HR = 1.81, 95% CI: 1.41–2.31). The OS and CSS nomograms, developed from multivariate Cox regression analyses, showed good performance, with AUCs of 0.858, 0.878, and 0.852 for predicting 1-year, 3-year, and 5-year OS, and AUCs of 0.859, 0.887, and 0.865 for 1-year, 3-year, and 5-year CSS in the testing set. The nomograms are accessible online (OS: https://zhmte.shinyapps.io/DynNomapp/; CSS: https://zhmty.shinyapps.io/DynNomapp/). Conclusions: LODDS serves as an independent prognostic factor in GEPNET. Online nomograms based on LODDS demonstrated effective performance in predicting OS and CSS in GEPNET patients, providing a convenient tool for clinical application.

Oronsky B, Ma PC, Morgensztern D, et al., 2017, Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas. Neoplasia, 19(12): 991–1002. https://doi.org/10.1016/j.neo.2017.09.002

Dasari A, Shen C, Halperin D, et al., 2017, Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol, 3(10): 1335–1342. https://doi.org/10.1001/jamaoncol.2017.0589

Aristizabal Prada ET, Auernhammer CJ, 2018, Targeted Therapy of Gastroenteropancreatic Neuroendocrine Tumours: Preclinical Strategies and Future Targets. Endocr Connect, 7(1): R1–R25. https://doi.org/10.1530/EC-17-0286

Cives M, Strosberg JR, 2018, Gastroenteropancreatic Neuroendocrine Tumors. CA Cancer J Clin, 68(6): 471–487. https://doi.org/10.3322/caac.21493

Martin JA, Warner RRP, Aronson A, et al., 2017, Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors. Pancreas, 46(9): 1214–1218. https://doi.org/10.1097/MPA.0000000000000921

Cai H, Xu T, Zhuang Z, et al., 2021, Value of the Log Odds of Positive Lymph Nodes for Prognostic Assessment of Colon Mucinous Adenocarcinoma: Analysis and External Validation. Cancer Med, 10(23): 8542–8557. https://doi.org/10.1002/cam4.4366

Wen J, Ye F, He X, et al., 2016, Development and Validation of A Prognostic Nomogram Based on the Log Odds of Positive Lymph Nodes (LODDS) for Breast Cancer. Oncotarget, 7(15): 21046–21053. https://doi.org/10.18632/oncotarget.8091

Da Costa PM, Lages P, Onofre S, et al., 2020, The Impact of Negative Lymph Nodes in the Survival Outcomes of pN+ Patients Following Radical Gastrectomy: The Inverse Lymph Node Ratio as A Better Score to Study Negative Lymph Nodes. Updates Surg, 72(4): 1031–1040. https://doi.org/10.1007/s13304-020-00757-y

Kuo YH, You JF, Hung HY, et al., 2022, Number of Negative Lymph Nodes with A Positive Impact on Survival of Stage III Colon Cancer; A Retrospective Observation Study for Right Side and Left Side Colon. BMC Cancer, 22(1): 126. https://doi.org/10.1186/s12885-021-09154-z

Jiang S, Zhao L, Xie C, et al., 2020, Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors. Front Endocrinol (Lausanne), 11: 402. https://doi.org/10.3389/fendo.2020.00402

Chen L, Zhou Z, Chen J, 2017, Interpretation and Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Patients with Gastroenteropancreatic Neuroendocrine Tumors. Zhonghua Wei Chang Wai Ke Za Zhi, 20(9): 972–976.

Feng Y, Wang Y, Xie Y, et al., 2021, Nomograms Predicting the Overall Survival and Cancer-Specific Survival of Patients with Stage IIIC1 Cervical Cancer. BMC Cancer, 21(1): 450. https://doi.org/10.1186/s12885-021-08209-5

Baqar AR, Wilkins S, Wang W, et al., 2020, Log Odds of Positive Lymph Nodes is Prognostically Equivalent to Lymph Node Ratio in Non-Metastatic Colon Cancer. BMC Cancer, 20(1): 762. https://doi.org/10.1186/s12885-020-07260-y

Xu Z, Berho ME, Becerra AZ, et al., 2017, Lymph Node Yield is An Independent Predictor of Survival in Rectal Cancer Regardless of Receipt of Neoadjuvant Therapy. Journal of Clinical Pathology, 70: 584–592. https://doi.org/10.1136/jclinpath-2016-203995

Suzuki H, Sasaki E, Takano G, et al., 2021, Lymph Node Ratio as A Predictor for Minor Salivary Gland Cancer in Head and Neck. BMC Cancer, 21(1): 1186. https://doi.org/10.1186/s12885-021-08877-3

Prassas D, Safi SA, Stylianidi MC, et al., 2022, N, LNR or LODDS: Which Is the Most Appropriate Lymph Node Classification Scheme for Patients with Radically Resected Pancreatic Cancer? Cancers (Basel), 14(7): 1834. https://doi.org/10.3390/cancers14071834

Lin Y, 2022, A Prognostic Nomogram for Stage II/III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection. BMC Surg, 22(1): 256. https://doi.org/10.1186/s12893-022-01710-z

Gu P, Deng J, Sun Z, et al., 2021, Superiority of Log Odds of Positive Lymph Nodes (LODDS) for Prognostic Prediction After Gastric Cancer Surgery: A Multi-Institutional Analysis of 7620 Patients in China. Surg Today, 51(1): 101–110. https://doi.org/10.1007/s00595-020-02091-7

Scarinci A, Di Cesare T, Cavaniglia D, et al., 2018, The Impact of Log Odds of Positive Lymph Nodes (LODDS) in Colon and Rectal Cancer Patient Stratification: A Single-Center Analysis of 323 Patients. Updates Surg, 70(1): 23–31. https://doi.org/10.1007/s13304-018-0519-3

Ramacciato G, Nigri G, Petrucciani N, et al., 2017, Prognostic Role of Nodal Ratio, LODDS, pN in Patients with Pancreatic Cancer with Venous Involvement. BMC Surg, 17(1): 109. https://doi.org/10.1186/s12893-017-0311-1

Xie S, Li L, Wang X, et al., 2021, Development and Validation of A Nomogram for Predicting the Overall Survival of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms. Medicine (Baltimore), 100(2): e24223. https://doi.org/10.1097/MD.0000000000024223

Fang C, Wang W, Feng X, et al., 2017, Nomogram Individually Predicts the Overall Survival of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms. Br J Cancer, 117(10): 1544–1550. https://doi.org/10.1038/bjc.2017.315